Yolanda Eby

5.6k total citations · 3 hit papers
21 papers, 2.8k citations indexed

About

Yolanda Eby is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Yolanda Eby has authored 21 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Yolanda Eby's work include SARS-CoV-2 and COVID-19 Research (5 papers), Cancer-related Molecular Pathways (5 papers) and Cervical Cancer and HPV Research (4 papers). Yolanda Eby is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Cancer-related Molecular Pathways (5 papers) and Cervical Cancer and HPV Research (4 papers). Yolanda Eby collaborates with scholars based in United States, Denmark and United Kingdom. Yolanda Eby's co-authors include David Sidransky, Wayne M. Koch, Ralph H. Hruban, Jay O. Boyle, Steven N. Goodman, Joseph Brennan, Paul Cairns, Li Mao, Kaori Tokino and Jef D. Boeke and has published in prestigious journals such as New England Journal of Medicine, The EMBO Journal and PLoS ONE.

In The Last Decade

Yolanda Eby

20 papers receiving 2.7k citations

Hit Papers

Molecular Assessment of Histopathological Staging in Squa... 1993 2026 2004 2015 1995 1995 1993 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yolanda Eby United States 17 1.4k 1.3k 907 618 508 21 2.8k
Janet M. Risk United Kingdom 31 482 0.3× 1.0k 0.8× 695 0.8× 522 0.8× 353 0.7× 82 2.5k
Daniel L. Stoler United States 24 578 0.4× 730 0.5× 231 0.3× 151 0.2× 541 1.1× 58 1.9k
D. P. Huang Hong Kong 20 1.1k 0.8× 761 0.6× 353 0.4× 287 0.5× 509 1.0× 27 2.0k
Régis Costello France 33 1.3k 1.0× 872 0.6× 409 0.5× 384 0.6× 309 0.6× 153 3.9k
Michel Barrois France 29 965 0.7× 1.2k 0.9× 103 0.1× 234 0.4× 403 0.8× 53 2.3k
Friedrich Kommoss Germany 29 684 0.5× 778 0.6× 75 0.1× 448 0.7× 355 0.7× 75 2.5k
Pathmanathan Rajadurai Malaysia 20 1.1k 0.8× 523 0.4× 121 0.1× 198 0.3× 402 0.8× 60 1.7k
Ying-Tai Jin Taiwan 21 572 0.4× 418 0.3× 169 0.2× 220 0.4× 179 0.4× 33 1.3k
Joseph C. K. Lee Hong Kong 17 678 0.5× 801 0.6× 126 0.1× 231 0.4× 444 0.9× 35 1.7k
Andreas Widschwendter Austria 24 488 0.4× 1.3k 0.9× 73 0.1× 237 0.4× 480 0.9× 56 2.2k

Countries citing papers authored by Yolanda Eby

Since Specialization
Citations

This map shows the geographic impact of Yolanda Eby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda Eby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda Eby more than expected).

Fields of papers citing papers by Yolanda Eby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolanda Eby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda Eby. The network helps show where Yolanda Eby may publish in the future.

Co-authorship network of co-authors of Yolanda Eby

This figure shows the co-authorship network connecting the top 25 collaborators of Yolanda Eby. A scholar is included among the top collaborators of Yolanda Eby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolanda Eby. Yolanda Eby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sulaiman, Andrew, Christi E. Marshall, Reinaldo E. Fernández, et al.. (2025). SARSCoV‐2 IgG antibodies in COVID‐19 convalescent plasma and conventional plasma units. Transfusion. 65(3). 446–452.
2.
Panda, Snigdha, Jennifer L. Alejo, Yolanda Eby, et al.. (2024). Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 79(3). 652–655. 2 indexed citations
3.
Karaba, Andrew H., Weiqiang Zhou, Shuai Li, et al.. (2022). Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 76(3). e495–e498. 3 indexed citations
4.
Zhu, Xianming, Ruchee Shrestha, Tania S. Bonny, et al.. (2022). Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals. PLoS ONE. 17(6). e0264298–e0264298. 1 indexed citations
5.
Karaba, Andrew H., Yolanda Eby, Jennifer L. Alejo, et al.. (2022). A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response. Transplantation. 106(7). 1440–1444. 43 indexed citations
6.
Sahasrabuddhe, Vikrant V., Patti E. Gravitt, S. Terence Dunn, et al.. (2014). Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Journal of Clinical Virology. 60(4). 414–417. 16 indexed citations
7.
Gravitt, Patti E., et al.. (2013). Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. Journal of Virological Methods. 189(1). 167–171. 23 indexed citations
8.
Marks, Morgan A., et al.. (2012). Comparison of normalization methods for measuring immune markers in cervical secretion specimens. Journal of Immunological Methods. 382(1-2). 211–215. 19 indexed citations
9.
Bolton, Eric C., et al.. (2005). Identification and characterization of critical cis-acting sequences within the yeast Ty1 retrotransposon. RNA. 11(3). 308–322. 23 indexed citations
10.
Eby, Yolanda, et al.. (2004). Local Definition of Ty1 Target Preference by Long Terminal Repeats and Clustered tRNA Genes. Genome Research. 14(7). 1232–1247. 30 indexed citations
11.
Merkulov, Gennady V., Joseph F. Lawler, Yolanda Eby, & Jef D. Boeke. (2001). Ty1 Proteolytic Cleavage Sites Are Required for Transposition: All Sites Are Not Created Equal. Journal of Virology. 75(2). 638–644. 23 indexed citations
12.
Brachmann, Rainer K., Kexin Yu, Yolanda Eby, Nikola P. Pavletich, & Jef D. Boeke. (1998). Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations. The EMBO Journal. 17(7). 1847–1859. 141 indexed citations
13.
Devine, Scott E., Stephanie L. Chissoe, Yolanda Eby, Richard K. Wilson, & Jef D. Boeke. (1997). A Transposon-Based Strategy for Sequencing Repetitive DNA in Eukaryotic Genomes. Genome Research. 7(5). 551–563. 36 indexed citations
14.
Reed, Andre L., Joseph A. Califano, Paul Cairns, et al.. (1996). High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.. PubMed. 56(16). 3630–3. 480 indexed citations
15.
Brennan, Joseph, Jay O. Boyle, Wayne M. Koch, et al.. (1995). Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck. New England Journal of Medicine. 332(11). 712–717. 506 indexed citations breakdown →
16.
Brennan, Joseph, Li Mao, Ralph H. Hruban, et al.. (1995). Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck. New England Journal of Medicine. 332(7). 429–435. 581 indexed citations breakdown →
17.
Cairns, P, Kaori Tokino, Yolanda Eby, & David Sidransky. (1995). Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.. PubMed. 55(2). 224–7. 84 indexed citations
18.
Johns, Michael M., Yolanda Eby, Douglas W. Ball, et al.. (1994). RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Human Molecular Genetics. 3(10). 1895–1897. 66 indexed citations
19.
Cairns, Paul, Kaori Tokino, Yolanda Eby, & David Sidransky. (1994). Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.. PubMed. 54(6). 1422–4. 149 indexed citations
20.
Boyle, Jay O., J Hakim, Wayne M. Koch, et al.. (1993). The incidence of p53 mutations increases with progression of head and neck cancer.. PubMed. 53(19). 4477–80. 502 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026